丹红注射液与稳心颗粒联合治疗老年冠心病合并心律失常临床研究  

Clinical Study on Elderly Coronary Heart Disease Arrhythmia Patients Treated by Danhong Injection Combined with Wenxin Granules

作　　者：张立军[1] 

机构地区：[1]成都大学校医院,四川成都610100

出　　处：《实用中西医结合临床》2011年第4期1-2,共2页Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine

摘　　要：目的:探讨丹红注射液联合稳心颗粒改善老年心律失常的有效性和安全性。方法:将 64 例冠心病合并心律失常患者随机分为实验组和对照组,分别给予丹红注射液联合稳心颗粒和普罗帕酮治疗 2 周,观察比较疗效和不良反应发生情况。结果:过早搏动总有效率实验组为 71.88%, 对照组为 50.00%, 差异有统计学意义 (P <0.05); 临床总有效率实验组为 78.12%, 对照组为53.12%,差异有统计学意义(P <0.05);实验组 CRP 水平降低比对照组更明显,差异有统计学意义(P <0.01)。结论:丹红注射液联合稳心颗粒改善老年心律失常临床疗效显著,且可明显降低 CRP 水平,值得临床推广应用。Objective：To investigate the efficacy and safety of Danhong injection combined with Wenxin granules in elderly coronary heart disease arrhythmia patients.Methods：64 Cases were randomly divided into experimental group and control group,Danhong injection combined with Wenxin granules and propafenone were separately given for 2 weeks.The effect and adverse reaction of two groups were observed and compared.Result：The total effective rate of premature beats were 71.88%（experimental group） and 50.00%（control group）,there was significant differrence（P0.05）.The total effective rate of clinic effect were 78.12%（experimental group） and 53.12%（control group）,there was significant differrence（P0.05）.The level of CRP of experimental group was lower than those of control group,there was significant differrence（P0.01）.Conclusion：Danhong injection combined with Wenxin granules in elderly coronary heart disease arrhythmia patients has notable curative effect and less adverse reactions,it is worthy of clinic application.

关 键 词：丹红注射液 稳心颗粒 老年冠心病 心律失常 

分 类 号：R541.7[医药卫生—心血管疾病]